Skip to content

Biomea Fusion, Inc.

BMEA· NasdaqCore metricsCIK 1840439

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -6.88%
Market cap
$41.03M
72.68M shares
Filings
292
$1.24B
Q3 2022
—
-$6.18M
Q3 2026N/M FY25 yoy
-$12.96M
Q3 2026N/M FY25 yoy
-$56.43M
Q3 2025derivedN/M FY24 yoy
-$0.09
Q3 2026N/M FY25 yoy
$26.40M
Q3 2026−4.2% FY25 yoy
$41.03M
—
—
5.4×
—
—

FY2025 figures · derived

Price

$0.564559.68%$0.8355past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

$1.86MFY 2025
$8.88M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,858,000reported
FY 20242024-12-31$5,644,000reported
FY 20232023-12-31$8,880,000reported

Pharmaceutical preparations

Biomea Fusion, Inc. is the 346th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Biomea Fusion, Inc. · CIK 1840439 · Engraved from SEC EDGAR